---
$id: https://graph.org.ai/products/commodity/51391724
$type: Product
source: UNSPSC
code: "51391724"
title: "Levisoprenaline"
class: "51391700"
classTitle: "Sympathomimetic or adrenergic amino alcohols"
family: "51390000"
familyTitle: "Sympathomimetic or adrenergic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Levisoprenaline

**UNSPSC Code**: 51391724
**Class**: [Sympathomimetic or adrenergic amino alcohols](Sympathomimetic or adrenergic amino alcohols.mdx)
**Family**: [Sympathomimetic or adrenergic drugs](../Sympathomimetic or adrenergic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a bronchodilator and beta-adrenergic agonist with the molecular formula C11H17NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 588N0603CT, chemically known as 1,2-benzenediol, 4-((1r)-1-hydroxy-2-((1-methylethyl)amino)ethyl)- but generally known as levisoprenaline, which bears US NIH Compound Identifier 5808. European Medicines Agency schedules Levisoprenaline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08460MIG. The term LEVISOPRENALINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). LEVISOPRENALINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule Levisoprenaline under HS 29225000 and SITC 51467. As of Q4 2014, LEVISOPRENALINE remains the US FDA Preferred Term for this commodity. Levisoprenaline bears US NLM identifiers UMLS ID C2697916 and NCI Concept Code C74197. SMILES: CC(C)NC[C@@H](C1CCC(C(C1)O)O)O.

